secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keros Therapeutics, Inc. (KROS)
CIK:        0001664710
Form:       8-K
Filed at:   2026-03-04T23:59:59+00:00
Accession:  0001664710-26-000021
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Keros Therapeutics updates corporate presentation; no material new disclosures in filing
--------------------------------------------------------------------------------

- Company furnished a corporate presentation dated March 2026 for investor meetings.
- Presentation is available on Keros's website; no forward-looking statements or specific data excerpted.
- No financial results, pipeline milestones, or guidance changes were disclosed in the filing text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1664710/000166471026000021/0001664710-26-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1664710/000166471026000021/kros-20260304.htm
  HTML page:      https://secwatch.observer/filing/0001664710-26-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer